Accelerate biotechnology

Batavia Biosciences receives grant to develop new vaccine against rotavirus

Leiden/Woburn, 21 September 2016 – Batavia Biosciences received an $8 million grant from the Bill & Melinda Gates Foundation to develop a low cost manufacturing process to bring an affordable rotavirus vaccine to the global health market. This vaccine aims to save many young children’s lives worldwide.   Rotavirus infection, associated with severe vomiting and…


Batavia Biosciences Receives Grant from the Bill & Melinda Gates Foundation to Support Vaccine Availability in Developing Countries

Advanced cell-line technology could reduce costs of vaccine production Leiden, The Netherlands, and Woburn, MA, 9th June 2016 Batavia Biosciences is committed to increase vaccine availability and affordability for the developing world and has received a $3.8 million grant from the Bill & Melinda Gates Foundation to fund this work. Despite many advances in manufacturing technologies…

COVID-19 Message

Please read the message from our executive management regarding the precautionary measures at Batavia Biosciences.